NuVasive (NUVA) Tops Q2 EPS by 6c; Enters Settlement with U.S. DOJ

Go back to NuVasive (NUVA) Tops Q2 EPS by 6c; Enters Settlement with U.S. DOJ

NuVasive (NUVA) PT Raised to $65 at Leerink Partners Amid Solid Q2

July 29, 2015 7:59 AM EDT

Leerink Partners analyst Richard Newitter reiterated an Outperform rating and boosted his price target on NuVasive (NASDAQ: NUVA) to $65.00 (from $57.00) following solid Q2 results.

Newitter commented, "NUVA's 2Q was solid with 8.5% cc rev growth & margin/EPS upside. 2015 guidance (rev unchgd; mgn/EPS... More

Brean Capital Raises Price Target on NuVasive (NUVA) Following 2Q EPS Beat

July 29, 2015 7:35 AM EDT

Brean Capital reiterated a Buy rating on NuVasive (NASDAQ: NUVA), and raised the price target to $56.00 (from $55.00), following a 2Q15 EPS beat. NUVA reported non-GAAP EPS of $0.31, $0.06 above consensus estimates of $0.25. Revenues for the quarter came in at $202.9M, versus consensus of $200.7M. NUVA... More

Northland Capital Markets Upgrades NuVasive (NUVA) to Outperform

July 29, 2015 7:06 AM EDT

Northland Capital Markets upgraded NuVasive (NASDAQ: NUVA) from Market Perform to Outperform with a price target of $68.00.

For an analyst ratings summary and ratings history on NuVasive click here. For more ratings news on NuVasive click here.

Shares of NuVasive closed at $50.47 yesterday.

... More